Deep Blue Medical Advances, Inc. — Form D
Deep Blue Medical Advances, Inc. of Durham, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-30. The offering totals $7.5M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-30
- Form: D
- Accession: 0001726572-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.0M
- Remaining: $466K
- Investors: 113
- Date of first sale: 2022-06-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450845
Issuer
- Name: Deep Blue Medical Advances, Inc.
- CIK: 0001726572
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 701 W. Main St, Durham, NC, 27701
- Phone: 408-242-9323
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Ken Gall | Director | Durham, NC |
| Howard Levinson | Promoter | Durham, NC |
| William Perry | Promoter | Washington, DC |
| Howard Levinson | Director | Durham, NC |
| Howard Levinson | Executive Officer | Durham, NC |
| William Perry | Director | Washington, DC |
| William Perry | Executive Officer | Washington, DC |
| Michael Bates | Director | Durham, NC |
| Neil Meyer | Director | Durham, NC |
| Brent Duncan | Director | Durham, NC |
| Robert Isaacs | Director | Hillsborough, NC |
| Robert Bonczek | Director | Hillsborough, NC |
Other filings by this issuer (5)
More